Paula Scholz

957 total citations
34 papers, 649 citations indexed

About

Paula Scholz is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Paula Scholz has authored 34 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Ophthalmology, 21 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Neurology. Recurrent topics in Paula Scholz's work include Retinal Diseases and Treatments (22 papers), Glaucoma and retinal disorders (17 papers) and Retinal and Optic Conditions (11 papers). Paula Scholz is often cited by papers focused on Retinal Diseases and Treatments (22 papers), Glaucoma and retinal disorders (17 papers) and Retinal and Optic Conditions (11 papers). Paula Scholz collaborates with scholars based in Germany, Switzerland and Netherlands. Paula Scholz's co-authors include Sascha Fauser, Lebriz Altay, Carel B. Hoyng, Claus Cursiefen, Sebastian Siebelmann, Mario Matthaei, Björn Bachmann, Camiel J.F. Boon, Myrte B. Breukink and Camiel J. F. Boon and has published in prestigious journals such as American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science and British Journal of Ophthalmology.

In The Last Decade

Paula Scholz

32 papers receiving 620 citations

Peers

Paula Scholz
Comparison fields: 5 of 47
  • Ophthalmology 565
  • Radiology, Nuclear Medicine and Imaging 346
  • Molecular Biology 94
  • Epidemiology 50
  • Biomedical Engineering 28
Maximino Abraldes Spain
Jeany Q. Li Germany
Hanna Lesiewska‐Junk Poland
Lebriz Ersoy Germany
Keiji Inagaki Japan
Reda Žemaitienė Lithuania
Feyzahan Ekici Türkiye
Maria Luz Cachulo Portugal
Jane Z. Kuo United States
Hümeyra Karacal United States
Maximino Abraldes Spain View profile →
Citations per field, relative to Paula Scholz
Paula Scholz · 1×
Citations per year, relative to Paula Scholz
Paula Scholz · 1×

Countries citing papers authored by Paula Scholz

Since Specialization
Citations

This map shows the geographic impact of Paula Scholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Scholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Scholz more than expected).

Fields of papers citing papers by Paula Scholz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Scholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Scholz. The network helps show where Paula Scholz may publish in the future.

Co-authorship network of co-authors of Paula Scholz

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Scholz. A scholar is included among the top collaborators of Paula Scholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Scholz. Paula Scholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration Ophthalmology Retina Frank G. Holz, Focke Ziemssen et al. 0
2 A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning Graefe s Archive for Clinical and Experimental Ophthalmology Matthias Gutfleisch, B. Heimes et al. 0
3 Aflibercept im klinischen Alltag: die AURIGA-Studie Die Ophthalmologie Michael Ulbig, Christian Brinkmann et al. 1
4 See clearer: survey on the subjective and objective information levels as well as perception and information transfer using virtual reality headsets in patients with diabetic macular edema receiving anti-VEGF treatment Graefe s Archive for Clinical and Experimental Ophthalmology Markus Schürks, Paula Scholz et al. 2
5 Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser Acta Ophthalmologica Thomas J. van Rijssen, Elon H. C. van Dijk et al. 22
6 The Cologne rebubbling study: a reappraisal of 624 rebubblings after Descemet membrane endothelial keratoplasty British Journal of Ophthalmology Sebastian Siebelmann, Paula Scholz et al. 23
7 Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial American Journal of Ophthalmology Thomas J. van Rijssen, Elon H. C. van Dijk et al. 32
8 Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy Graefe s Archive for Clinical and Experimental Ophthalmology Thomas J. van Rijssen, Elon H. C. van Dijk et al. 8
9 Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser. American Journal of Ophthalmology Thomas J. van Rijssen, Paula Scholz et al. 6
10 Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3 American Journal of Ophthalmology Thomas J. van Rijssen, Elon H. C. van Dijk et al. 44
11 Intraoperative changes in corneal structure during excimer laser phototherapeutic keratectomy (PTK) assessed by intraoperative optical coherence tomography Graefe s Archive for Clinical and Experimental Ophthalmology Sebastian Siebelmann, Jens Horstmann et al. 16
12 Mikroskopintegrierte intraoperative optische Kohärenztomographie bei der Narkoseuntersuchung von pädiatrischen Patienten Der Ophthalmologe Sebastian Siebelmann, Björn Bachmann et al. 4
13 A genetic variant in the NR3C2 gene, encoding the mineralocorticoid receptor, is associated with chronic central serous chorioretinopathy Acta Ophthalmologica Rosa L. Schellevis, Elon H. C. van Dijk et al. 1
14 Anterior segment optical coherence tomography for the diagnosis of corneal dystrophies according to the IC3D classification Survey of Ophthalmology Sebastian Siebelmann, Paula Scholz et al. 43
15 A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders Advances in Therapy Paula Scholz, Lebriz Altay et al. 111
16 Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy JAMA Ophthalmology Elon H. C. van Dijk, Rosa L. Schellevis et al. 56
17 Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration Eye Philip Enders, Paula Scholz et al. 8
18 Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy Ophthalmologica Paula Scholz, Lebriz Ersoy et al. 57
19 Metallothionein, copper and zinc in fetal and neonatal human liver: changes during development Toxicology Letters Dominik Klein, Paula Scholz et al. 33
20 Methämoglobingehalt, Methämoglobinreduktion und Sauerstoffverbrauch in jungen und alten Erythrozyten Annals of Hematology Klaus Betke, E. Kleihauer et al. 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026